Willard H. Dere - 01 Apr 2024 Form 4 Insider Report for Metagenomi, Inc. (MGX)

Role
Director
Signature
/s/ Matthew L. Wein, attorney-in-fact
Issuer symbol
MGX
Transactions as of
01 Apr 2024
Transactions value $
$0
Form type
4
Filing time
03 Apr 2024, 20:11:52 UTC
Previous filing
08 Feb 2024
Next filing
08 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGX Stock Option (Right to Buy) Award $0 +78.6K $0.00 78.6K 01 Apr 2024 Common Stock 78.6K $10.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 33.33% of the shares subject to this option shall vest and become exercisable on April 1, 2025, with the remainder vesting in 24 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.